What is Bioplexus?
BioPlexus is a specialized supplier of medical-grade silicone products, catering to healthcare professionals and distributors globally. Their product portfolio encompasses essential items such as silicone blocks for prosthetic applications, sheeting utilized in various medical procedures, and pads designed for laboratory use. Additionally, BioPlexus offers SpectraFilm adhesive gel sheets, a solution for scar treatment. The company's operational ethos is centered on addressing diverse medical requirements with an emphasis on prompt, same-day product delivery, positioning them as a reliable partner in the healthcare supply chain.
How much funding has Bioplexus raised?
Bioplexus has raised a total of $37K across 1 funding round:
Debt
$37K
Debt (2021): $37K with participation from PPP
Key Investors in Bioplexus
PPP
Public-Private Partnership
What's next for Bioplexus?
With the recent influx of substantial expansion capital, Bioplexus is poised for accelerated growth and market penetration. The company's strategic focus will likely involve scaling its manufacturing capabilities, broadening its distribution network, and potentially investing in research and development for new silicone-based medical solutions. This investment signals confidence from stakeholders in Bioplexus's business model and its capacity to meet the evolving demands of the medical device and prosthetics industries. Future developments may include enhanced product lines and expanded global reach.
See full Bioplexus company page
